S Bibi, I Ullah, B Zhu, M Adnan, R Liaqat, WB Kong… - Scientific reports, 2021 - nature.com
Tuberculosis (TB) kills more individuals in the world than any other disease, and a threat made direr by the coverage of drug-resistant strains of Mycobacterium tuberculosis (Mtb) …
K Kumar, CL Daley, DE Griffith… - European Respiratory …, 2022 - Eur Respiratory Soc
Nontuberculous mycobacterial pulmonary disease (NTM-PD) remains a challenging condition to diagnose and treat effectively. Treatment of NTM-PD is prolonged, frequently …
L Boeck, S Burbaud, M Skwark, WH Pearson… - Nature …, 2022 - nature.com
The medical and scientific response to emerging and established pathogens is often severely hampered by ignorance of the genetic determinants of virulence, drug resistance …
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a rapidly growing infectious disease, widely spread with high mortality rates. Since the release of the SARS …
Mycobacterium tuberculosis (Mtb) is a successful pathogen in the history of mankind. A high rate of mortality and morbidity raises the need for vaccine development. Mechanism of …
Tuberculosis (TB) and leprosy are mycobacterial infections caused by Mycobacterium tuberculosis and Mycobacterium leprae respectively. These diseases continue to be …
Tuberculosis (TB) a disease caused by Mycobacterium tuberculosis (Mtb) poses a significant threat to human life, and current BCG vaccinations only provide sporadic …
KK Roy, MA Wani - Expert Opinion on Drug Discovery, 2020 - Taylor & Francis
Introduction: Tuberculosis (TB) is a leading infectious disease worldwide whose chemotherapy is challenged by the continued rise of drug resistance. This epidemic urges …
S Sur, T Patra, M Karmakar… - Critical Reviews in …, 2023 - Taylor & Francis
Mycobacterium abscessus is a nontuberculous mycobacterium, associated with broncho- pulmonary infections in individuals suffering from cystic fibrosis, bronchiectasis, and …